Wednesday, December 20, 2023 8:16:26 AM
We did it! 2023 Annual Report and Legal Opinion are in. Once more the Company crossed the mark of Million Dollars in sales, without one share dilution, while cutting costs and retiring over $100k of debt. This is a solid base to move on what is being prepared for 2024. $HBRM
— Herborium (OTC: HBRM) (@Herborium1) December 20, 2023
“Be Fearful When Others Are Greedy and Greedy When Others Are Fearful”
Warren Buffett
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM